Holowka Thomas, Bucala Richard
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, USA.
Trop Med Infect Dis. 2020 Mar 20;5(1):46. doi: 10.3390/tropicalmed5010046.
Macrophage migration inhibitory factor (MIF) is an immunoregulatory cytokine that has been extensively characterized in human disease and in mouse models. Its pro-inflammatory functions in mammals includes the retention of tissue macrophages and a unique ability to counteract the immunosuppressive activity of glucocorticoids. MIF also acts as a survival factor by preventing activation-induced apoptosis and by promoting sustained expression of inflammatory factors such as TNF-α and nitric oxide. The pro-inflammatory activity of MIF has been shown to be protective against infection in mouse models of cutaneous disease, however the precise role of this cytokine in human infections is less clear. Moreover, various species of produce their own MIF orthologs, and there is evidence that these may drive an inflammatory environment that is detrimental to the host response. Herein the immune response to in mouse models and humans will be reviewed, and the properties and activities of mammalian and MIF will be integrated into the current understandings in this field. Furthermore, the prospect of targeting MIF for therapeutic purposes will be discussed.
巨噬细胞移动抑制因子(MIF)是一种免疫调节细胞因子,在人类疾病和小鼠模型中已得到广泛研究。它在哺乳动物中的促炎功能包括保留组织巨噬细胞以及具有抵消糖皮质激素免疫抑制活性的独特能力。MIF还通过防止激活诱导的细胞凋亡以及促进炎症因子如肿瘤坏死因子-α和一氧化氮的持续表达而发挥生存因子的作用。在皮肤疾病的小鼠模型中,MIF的促炎活性已显示出对感染具有保护作用,然而这种细胞因子在人类感染中的确切作用尚不清楚。此外,各种物种都产生自己的MIF直系同源物,并且有证据表明这些可能会驱动对宿主反应有害的炎症环境。本文将综述小鼠模型和人类对[原文此处可能缺失具体病原体名称]的免疫反应,并将哺乳动物和[原文此处可能缺失具体病原体名称]MIF的特性和活性纳入该领域的当前认识中。此外,还将讨论以[原文此处可能缺失具体病原体名称]MIF为治疗靶点的前景。